BioSpace News Archive

Policy

Palliare Announces EU CE Mark Approval Under New Medical Devices Regulation

Palliare, a leading developer of advanced insufflation technologies, has received EU CE Mark certification under the new EU Medical Devices Regulation for its EVA15 insufflator and smoke evacuation system.

July 28, 2023
·
3 min read
Policy

Curium Receives Marketing Authorization in the EU for PYLCLARI™, an Innovative 18F-PSMA PET Tracer Indicated in Adults With Prostate Cancer

Curium announced that the European Commission has granted marketing authorization for PYLCLARI™ indicated for the detection of prostate-specific membrane antigen positive lesions with positron emission tomography in adults with prostate cancer.

July 28, 2023
·
2 min read
Business

Stevanato Group Reports Second Quarter 2023 Financial Results

Stevanato Group S.p.A. today announced its financial results for the second quarter of 2023.

July 28, 2023
·
18 min read
Business

OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center

OKYO Pharma Limited is pleased to announce a new agreement with Tufts Medical Center to conduct a 40-patient open-label clinical trial evaluating the efficacy and safety of OK-101 in patients with neuropathic corneal pain (“NCP”).

July 28, 2023
·
6 min read
Business

Press release: Online availability of Sanofi’s half-year financial report for 2023

Sanofi announces that its half-year financial report for the period ending June 30, 2023 is now available and has been filed with the French market regulator Autorité des marchés financiers and submitted to the U.S. Securities and Exchange Commission under form 6-K.

July 28, 2023
·
1 min read
Latest Updates of 7 Viva’s Portfolio Companies

In the face of ever-changing circumstances, technological innovation remains the eternal driving force behind the long-term growth of biopharmaceutical companies.

July 28, 2023
·
11 min read
Business

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

Clinical stage pharmaceutical development company, Incannex Healthcare Limited is pleased to provide its quarterly activities report and appendix 4C for the period ended 30 June 2023.

July 28, 2023
·
21 min read
Business

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results

Fate Therapeutics, Inc. today announced that the Company will host a conference call and live audio webcast on Tuesday, August 8, 2023 at 5:00 PM ET to report its second quarter 2023.

July 28, 2023
·
1 min read
Genetown

Merus Announces Two Clinical Abstracts on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) non-small cell lung cancer (NSCLC) and Pancreatic Cancer (PDAC) Selected for Presentation at the ESMO Congress 2023

Merus N.V. today announced two abstracts were selected for presentation at the European Society for Medical Oncology Congress (ESMO) 2023.

July 28, 2023
·
5 min read
Business

IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center

IO Biotech announced today that the University of California Davis Comprehensive Cancer Center has dosed the first patient in its investigator-initiated trial which aims to evaluate IO102-IO103, the company’s investigational immune-modulating cancer vaccine.

July 28, 2023
·
4 min read